Pinnacle Wealth Management Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Buy |
757
+26
| +4% | +$11.6K | 0.03% | 278 |
|
|
2025
Q1 | $354K | Buy |
731
+45
| +7% | +$21.8K | 0.03% | 258 |
|
|
2024
Q4 | $276K | Sell |
686
-25
| -4% | -$10.1K | 0.03% | 293 |
|
|
2024
Q3 | $331K | Buy |
711
+3
| +0.4% | +$1.4K | 0.03% | 260 |
|
|
2024
Q2 | $332K | Buy |
708
+33
| +5% | +$15.5K | 0.03% | 254 |
|
|
2024
Q1 | $282K | Buy |
675
+25
| +4% | +$10.5K | 0.03% | 273 |
|
|
2023
Q4 | $264K | Hold |
650
| – | – | 0.03% | 272 |
|
|
2023
Q3 | $226K | Sell |
650
-10
| -2% | -$3.48K | 0.03% | 281 |
|
|
2023
Q2 | $232K | Sell |
660
-40
| -6% | -$14.1K | 0.03% | 288 |
|
|
2023
Q1 | $221K | Buy |
+700
| New | +$221K | 0.03% | 283 |
|